Literature DB >> 24035113

Second primary tumors and myeloperoxidase expression in buccal mucosal squamous cell carcinoma.

Wei-Ming Lai1, Chien-Chou Chen, Jang-Hwa Lee, Chia-Jung Chen, Jyh-Seng Wang, Yu-Yi Hou, Huei-Han Liou, Hung-Chih Chen, Ting-Ying Fu, Yi-Cheng Lee, Luo-Ping Ger.   

Abstract

OBJECTIVE: The present study investigated the relationship between the expression of manganese superoxide dismutase (MnSOD), catalase, glutathione peroxidase (GPx), and myeloperoxidase (MPO) in buccal mucosal squamous cell carcinoma (SCC), and the risk of second primary tumors (SPTs). STUDY
DESIGN: Immunohistochemistry was performed to examine the expression of MnSOD, GPx, catalase, and MPO in tissue microarray slides of 173 male patients with buccal mucosal SCC who had undergone potentially curative resections.
RESULTS: Forty-five (26.01%) patients developed SPTs. The prevalent subsites of SPTs were buccal mucosa (48.89%), tongue (13.33%), and lip (11.11%). High expression level of MPO was correlated with an increased risk of SPTs, even after adjustment for development of clinicopathologic parameters (high vs. low expression, adjusted hazard ratio = 3.89; 95% confidence interval, 1.33-11.41; P = .013).
CONCLUSIONS: SPTs are common in male buccal mucosal SCC patients. Higher MPO expression in buccal mucosal SCC is a risk factor for SPTs.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24035113     DOI: 10.1016/j.oooo.2013.06.018

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  1 in total

1.  Molecular immuno-imaging improves tumor detection in head and neck cancer.

Authors:  Jing-Hui Li; Reza Forghani; Lionel Bure; Gregory R Wojtkiewicz; Yue Wu; Yoshiko Iwamoto; Muhammad Ali; Anning Li; Cuihua Wang; Negin Jalali Motlagh; Andreas I Papadakis; Marc P Pusztaszeri; Alan Spatz; Hugh Curtin; Ying-Sheng Cheng; John W Chen
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.